Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Cureus ; 14(2): e22035, 2022 Feb.
Article in English | MEDLINE | ID: mdl-35340506

ABSTRACT

Background In 2020, we published findings on reported outcomes of anterior cervical decompression and fusion surgery among neurosurgeons in Africa and North America. We found more similarities in outcomes than expected, however, differences still existed. Most notable was the length of stay of patients postoperatively in Africa compared to North America. We sought to examine the neurosurgical practices more closely at a single hospital in Ethiopia and compare it to our own institution, the University of Missouri in Columbia (UMC). Methods Two authors spent one week at Aabet Hospital (AH) in Ethiopia. Throughout the week, one author rotated in the clinic and OR gathering the information. Data collection for patients at UMC was collected through retrospective chart review over one week. Results A total of eight elective surgeries and four emergency procedures occurred at AH and 18 clinic patients were included in the study. The intraoperative data was collected during the elective procedures at AH. At UMC there were 99 clinic patients, and 29 elective surgeries and one emergency procedure were performed. Procedures at both institutions included cranial, spinal, vascular, and implantable/other cases. Distance travelled by patients to UMC was an average of 57 miles compared to 85 miles at AH. The median pre-op and post-op stays at AH were 2.5 and 6 days compared to 0.2 and 2.1 at UMC, respectively. Blood loss was greater at AH with a median blood loss of 175 mL. Median blood loss at UMC was 50 mL. Conclusion We found notable differences among neurosurgical practice and patient demographics at AH compared to UMC. This information will serve as the cornerstone for gathering more information about neurosurgical practice in Ethiopia where electronic medical records are unavailable.

3.
Ann Oncol ; 28(10): 2567-2574, 2017 Oct 01.
Article in English | MEDLINE | ID: mdl-28961829

ABSTRACT

BACKGROUND: The burden of cancer in China is high, and it is expected to further increase. Information on cancers attributable to potentially modifiable risk factors is essential in planning preventive measures against cancer. We estimated the number and proportion of cancer deaths and cases attributable to ever-smoking, second-hand smoking, alcohol drinking, low fruit/vegetable intake, excess body weight, physical inactivity, and infections in China, using contemporary data from nationally representative surveys and cancer registries. METHODS: The number of cancer deaths and cases in 2013 were obtained from the National Central Cancer Registry of China and data on most exposures were obtained from the China National Nutrition and Health Survey 2002 or 2006 and Global Adult Tobacco Smoking 2010. We used a bootstrap simulation method to calculate the number and proportion of cancer deaths and cases attributable to risk factors and their corresponding 95% confidence intervals (CIs), allowing for uncertainty in data. RESULTS: Approximately 718 000 (95% CI 702 100-732 200) cancer deaths in men and 283 100 (278 800-288 800) cancer deaths in women were attributable to the studied risk factors, accounting for 52% of all cancer deaths in men and 35% in women. The numbers for incident cancer cases were 952 500 (95% CI 934 200-971 400) in men and 442 700 (437 200-447 900) in women, accounting for 47% of all incident cases in men and 28% in women. The greatest proportions of cancer deaths attributable to risk factors were for smoking (26%), HBV infection (12%), and low fruit/vegetable intake (7%) in men and HBV infection (7%), low fruit/vegetable intake (6%), and second-hand smoking (5%) in women. CONCLUSIONS: Effective public health interventions to eliminate or reduce exposure from these risk factors, notably tobacco control and vaccinations against carcinogenic infections, can have considerable impact on reducing the cancer burden in China.


Subject(s)
Infections/mortality , Life Style , Neoplasms/microbiology , Neoplasms/mortality , Adult , Age Factors , Aged , Aged, 80 and over , Alcohol Drinking/epidemiology , China/epidemiology , Female , Humans , Infections/pathology , Male , Middle Aged , Neoplasms/pathology , Registries , Risk Factors , Smoking/epidemiology
4.
Ann Oncol ; 26(12): 2398-407, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26504151

ABSTRACT

BACKGROUND: Breastfeeding is inversely associated with overall risk of breast cancer. This association may differ in breast cancer subtypes defined by receptor status, as they may reflect different mechanisms of carcinogenesis. We conducted a systematic review and meta-analysis of case-control and prospective cohort studies to investigate the association between breastfeeding and breast cancer by estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status. DESIGN: We searched the PubMed and Scopus databases and bibliographies of pertinent articles to identify relevant articles and used random-effects models to calculate summary odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: This meta-analysis represents 27 distinct studies (8 cohort and 19 case-control), with a total of 36 881 breast cancer cases. Among parous women, the risk estimates for the association between ever (versus never) breastfeeding and the breast cancers negative for both ER and PR were similar in three cohort and three case-control studies when results were adjusted for several factors, including the number of full-term pregnancies (combined OR 0.90; 95% CI 0.82-0.99), with little heterogeneity and no indication of publication bias. In a subset of three adjusted studies that included ER, PR, and HER2 status, ever breastfeeding showed a stronger inverse association with triple-negative breast cancer (OR 0.78; 95% CI 0.66-0.91) among parous women. Overall, cohort studies showed no significant association between breastfeeding and ER+/PR+ or ER+ and/or PR+ breast cancers, although one and two studies (out of four and seven studies, respectively) showed an inverse association. CONCLUSIONS: This meta-analysis showed a protective effect of ever breastfeeding against hormone receptor-negative breast cancers, which are more common in younger women and generally have a poorer prognosis than other subtypes of breast cancer. The association between breastfeeding and receptor-positive breast cancers needs more investigation.


Subject(s)
Breast Feeding , Breast Neoplasms/metabolism , Breast Neoplasms/prevention & control , Receptor, ErbB-2/biosynthesis , Receptors, Estrogen/biosynthesis , Receptors, Progesterone/biosynthesis , Breast Feeding/trends , Case-Control Studies , Cohort Studies , Female , Humans , Prospective Studies , Risk Factors
5.
Int J Cancer ; 135(3): 702-9, 2014 Aug 01.
Article in English | MEDLINE | ID: mdl-24375396

ABSTRACT

There is little information on breast cancer (BC) survival in Ethiopia and other parts of sub-Saharan Africa. Our study estimated cumulative probabilities of distant metastasis-free survival (MFS) in patients at Addis Ababa (AA) University Radiotherapy Center, the only public oncologic institution in Ethiopia. We analyzed 1,070 females with BC stage 1-3 seen in 2005-2010. Patients underwent regular follow-up; estrogen receptor-positive and -unknown patients received free endocrine treatment (an independent project funded by AstraZeneca Ltd. and facilitated by the Axios Foundation). The primary endpoint was distant metastasis. Sensitivity analysis (worst-case scenario) assumed that patients with incomplete follow-up had events 3 months after the last appointment. The median age was 43.0 (20-88) years. The median tumor size was 4.96 cm [standard deviation (SD) 2.81 cm; n = 709 information available]. Stages 1, 2 and 3 represented 4, 25 and 71%, respectively (n = 644). Ductal carcinoma predominated (79.2%, n = 1,070) as well as grade 2 tumors (57%, n = 509). Median follow-up was 23.1 (0-65.6) months, during which 285 women developed metastases. MFS after 2 years was 74% (69-79%), declining to 59% (53-64%) in the worst-case scenario. Patients with early stage (1-2) showed better MFS than patients with stage 3 (85 and 66%, respectively). The 5-year MFS was 72% for stages 1 and 2 and 33% for stage 3. We present a first overview on MFS in a large cohort of female BC patients (1,070 patients) from sub-Saharan Africa. Young age and advanced stage were associated with poor outcome.


Subject(s)
Breast Neoplasms/mortality , Carcinoma, Ductal, Breast/mortality , Carcinoma, Lobular/mortality , Adult , Aged , Aged, 80 and over , Breast Neoplasms/pathology , Breast Neoplasms/therapy , Carcinoma, Ductal, Breast/pathology , Carcinoma, Ductal, Breast/therapy , Carcinoma, Lobular/pathology , Carcinoma, Lobular/therapy , Cohort Studies , Combined Modality Therapy , Ethiopia/epidemiology , Female , Follow-Up Studies , Humans , Middle Aged , Neoplasm Grading , Neoplasm Metastasis , Neoplasm Staging , Prognosis , Survival Rate , Young Adult
6.
Prostate Cancer Prostatic Dis ; 16(2): 176-80, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23338555

ABSTRACT

BACKGROUND: Previous studies have reported higher rates of advanced Gleason score among black versus white men with prostate cancer in the United States. However, few studies have examined if elevated Gleason scores among black men vary by country of birth. We examined differences in prostate cancer disease severity among US black men born in the United States and in Jamaica, West Africa and other sub-Saharan Africa countries. METHODS: Our study included 19 798 US-born, 267 Jamaican-born, and 246 West African-born black men diagnosed with prostate cancer during 2004-2009 in the 18 Surveillance Epidemiology and End Results population-based cancer registries. We evaluated the association of advanced Gleason score (7-10), as well as PSA levels and stage by country of origin adjusting for age, and county-level income. RESULTS: Among men with known Gleason score, the percentage of advanced Gleason score (scores 7-10) was 61.11% in Jamaican-born, 60.99% in West African-born and 58.26% in US-born black men (P-value=0.49). In a multivariable analysis among black men, there were no differences in advanced Gleason score (scores 7-10 versus 2-6) by country of origin. Mean PSA level (range 12.8-13.1 ng ml(-1)) did not vary among black men (P-value=0.94) in unadjusted and adjusted results. CONCLUSIONS: Similar Gleason score among US-born, African and Caribbean-born black men were observed. Future more detailed studies are needed to elucidate if these similarities are a result of similar early detection practices or shared risk factors.


Subject(s)
Prostatic Neoplasms/pathology , Africa, Western/ethnology , Black or African American , Aged , Humans , Jamaica/ethnology , Kallikreins/blood , Male , Middle Aged , Multivariate Analysis , Neoplasm Grading , Prostate-Specific Antigen/blood , Prostatic Neoplasms/blood , Prostatic Neoplasms/epidemiology , Prostatic Neoplasms/ethnology , SEER Program , United States/epidemiology
7.
Leukemia ; 26(4): 623-32, 2012 Apr.
Article in English | MEDLINE | ID: mdl-21960246

ABSTRACT

Despite advances in treatment and outcomes for patients with pediatric acute lymphoblastic leukemia (ALL), there continue to be subsets of patients who are refractory to standard chemotherapy and hematopoietic stem cell transplant. Therefore, novel gene targets for therapy are needed to further advance treatment for this disease. RNA interference technology has identified survivin as a potential therapeutic target. Survivin, a member of the inhibitor of apoptosis (IAP) proteins and chromosome passenger complex, is expressed in hematologic malignancies and overexpressed in relapsed pediatric ALL. Our studies show that survivin is uniformly expressed at high levels in multiple pediatric ALL cell lines. Furthermore, silencing of survivin expression in pediatric ALL cell lines as well as primary leukemic blasts reduces viability of these cells. This includes cell lines derived from patients with relapsed disease featuring cytogenetic anomalies such as t(12;21), Philadelphia chromosome t(9;22), t(1;19) as well as a cell line carrying t(17;19) from a patient with de novo ALL. Furthermore, inhibition of survivin increases p53-dependent apoptosis that can be rescued by inhibition of p53. Finally, a screen of randomly selected primary patient samples confirms that survivin-specific small interfering RNA and survivin-targeted drug, YM155, effectively reduce viability of leukemic blasts.


Subject(s)
Inhibitor of Apoptosis Proteins/antagonists & inhibitors , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Tumor Suppressor Protein p53/antagonists & inhibitors , Apoptosis , Benzamides , Cell Division , Cell Line, Tumor , Fusion Proteins, bcr-abl/antagonists & inhibitors , G2 Phase , Humans , Imatinib Mesylate , Piperazines/therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Pyrimidines/therapeutic use , Survivin
8.
J Epidemiol Community Health ; 65(3): 211-7, 2011 Mar.
Article in English | MEDLINE | ID: mdl-19959651

ABSTRACT

BACKGROUND: Studies have found significant race/ethnic and age differences in receipt of adjuvant chemotherapy for stages III colon and II/III rectal cancers. Little is known about the role of neighbourhood factors in these disparities. METHODS: The 4748 Black and White patients from the Georgia Comprehensive Cancer Registry were diagnosed with stages III colon and II/III rectal cancers between 2000 and 2004. Neighbourhood poverty, segregation (% Black residents) and rurality were linked to each patient using census tract identifiers. Multilevel analyses explored the role of neighbourhood characteristics and the nested association of patient race within categories of neighbourhoods in receipt of chemotherapy. RESULTS: Odds of receiving chemotherapy for urban and suburban patients were 38% (95% CI 1.09 to 1.74) and 53% (95% CI 1.20 to 1.94) higher than for rural patients. However, odds of receiving chemotherapy for urban Black patients were 24% (95% CI 0.62 to 0.94) lower than for their White counterparts. Receipt of chemotherapy did not significantly differ between Blacks and Whites residing in suburban or rural areas. CONCLUSION: Black-White disparities in receipt of chemotherapy among Georgia colorectal cancer patients were confined to urban patients. Disparities in receipt of this treatment for rural patients were found irrespective of patient race. Our findings highlight geographic areas where targeted interventions might be needed.


Subject(s)
Chemotherapy, Adjuvant/statistics & numerical data , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/ethnology , Health Status Disparities , Poverty/ethnology , Residence Characteristics , Adolescent , Adult , Aged , Aged, 80 and over , Black People/statistics & numerical data , Colorectal Neoplasms/epidemiology , Confidence Intervals , Female , Georgia/epidemiology , Humans , International Classification of Diseases , Male , Middle Aged , Multilevel Analysis , Neoplasm Staging , Poverty/statistics & numerical data , Prejudice , Rural Population/statistics & numerical data , Suburban Population/statistics & numerical data , Urban Population/statistics & numerical data , White People/statistics & numerical data
9.
BMC Blood Disord ; 9: 7, 2009 Sep 07.
Article in English | MEDLINE | ID: mdl-19735547

ABSTRACT

BACKGROUND: In Ethiopia, the existence of iron deficiency anemia is controversial despite the fact that Ethiopia is one of the least developed in Africa with a high burden of nutrient deficiencies. METHODS: The first large nutrition study of a representative sample of women in Ethiopia was conducted from June to July 2005 and a systematically selected sub-sample of 970 of these subjects, 15 to 49 years old, were used in this analysis of nutritional anemia. Hemoglobin was measured from capillary blood using a portable HemoCue photometer. For serum ferritin, venous blood from antecubital veins was measured by an automated Elecsys 1020 using commercial kits. Diets were assessed via simplified food frequency questionnaire. The association of anemia to demographic and health variables was tested by chi-square and a stepwise backward logistic regression model was applied to test the significant associations observed in chi square tests. RESULTS: Mean hemoglobin +/- SD was 11.5 +/- 2.1 g/dL with a 29.4% prevalence of anemia. Mean serum ferritin was 58 +/- 41.1 ug/L with a 32.1% prevalence of iron deficiency. The overall prevalence rate of iron deficiency anemia was 18.0%. Prevalence of anemia, iron deficiency, and iron deficiency anemia was highest among those 31-49 years old (p < 0.05). Intake of vegetables less than once a day and meat less than once a week was common and was associated with increased anemia (p = 0.001). Although the prevalence of anemia was slightly higher among women with parasitic infestation the difference was not significant (p = 0.9). Nonetheless, anemia was significantly higher in women with history of illness and the association was retained even when the variable was adjusted for its confounding effect in the logistic regression models (AOR = 0.3; 95%CI = 0.17 to 0.5) signifying that the most probable causes of anemia is nutrition related and to some extent chronic illnesses. CONCLUSION: Moderate nutritional anemia in the form of iron deficiency anemia is a problem in Ethiopia and therefore, the need for improved supplementation to vulnerable groups is warranted to achieve the United Nation's Millennium Development Goals. Chronic illnesses are another important cause of anemia.

11.
J Natl Cancer Inst ; 93(9): 678-83, 2001 May 02.
Article in English | MEDLINE | ID: mdl-11333289

ABSTRACT

BACKGROUND: It is not yet clear whether increasing melanoma incidence is real or whether recent incidence trends mainly reflect improved diagnosis. To address this question, we examined the most recent melanoma incidence patterns among the white population stratified by sex, age, tumor stage, and tumor thickness by use of data from the Surveillance, Epidemiology, and End Results Program. METHODS: We examined log-transformed age-specific rates for melanoma by 5-year age groups and time periods by year of diagnosis and birth cohort. Melanoma trends were further examined among broader age groups (<40 years, 40-59 years, and > or =60 years) by tumor stage and tumor thickness. Rates were age-adjusted to the 1970 U.S. standard population, and trends were tested by use of a two-sided Student's t test. RESULTS: Melanoma incidence increased in females born since the 1960s. From 1974-1975 through 1988-1989, upward trends for the incidence of localized tumors and downward trends for the incidence of distant-stage tumors occurred in the age group under 40 years. In the more recent time period, 1990-1991 through 1996-1997, age specific rates among females compared with males generally remained stable or declined more for distant-stage tumors and increased less for local-stage tumors. Thin tumors (<1 mm) increased statistically significantly in all age groups (P<.05 for all), except in men under age 40 years. In contrast, rates for thick tumors (> or =4 mm) increased statistically significantly (P =.0003) only in males aged 60 years and older. CONCLUSION: Melanoma incidence may well continue to rise in the United States, at least until the majority of the current population in the middle-age groups becomes the oldest population. The recent trends may reflect increased sunlight exposure.


Subject(s)
Melanoma/epidemiology , Skin Neoplasms/epidemiology , Adult , Age Factors , Aged , Female , Humans , Incidence , Male , Melanoma/ethnology , Middle Aged , Sex Factors , Skin Neoplasms/ethnology , Time Factors , United States/epidemiology , White People
12.
J Natl Cancer Inst ; 93(4): 277-83, 2001 Feb 21.
Article in English | MEDLINE | ID: mdl-11181774

ABSTRACT

BACKGROUND: Previous age-period-cohort analyses of lung cancer incidence and mortality rates in the United States have demonstrated a decrease in risk by birth cohort through 1950, consistent with declining trends in smoking prevalence. This study was conducted to examine recent lung cancer trends, including trends among the cohorts born after 1950. METHODS: Lung cancer mortality rates from 1970 through 1997 for whites aged 24--83 years and for blacks aged 30--83 years were investigated. Using age--period--cohort analyses with 2-year age and 2-year calendar-period intervals, we examined changes in the slope of the trends in birth-cohort and calendar-period effects. All statistical tests are two-sided. RESULTS: There was an unexpected, statistically significant moderation in the rate of decrease of the birth-cohort trend in lung cancer mortality for whites born after 1950, with a corresponding smaller and statistically nonsignificant moderation for blacks. These data are consistent with smoking initiation rates: Rates of both cigarette and marijuana smoking initiation increased for children aged 12--17 years from 1965 through 1977. There was a statistically significant decrease in the slope of the calendar-period trend for lung cancer mortality in 1990 for both whites and blacks that was observed primarily in people 55 years of age and older. CONCLUSIONS AND IMPLICATIONS: The birth-cohort pattern of lung cancer mortality after 1950 appears to reflect the early impact of teenage cigarette smoking on lung cancer risk in people under the age of 45 years, although a contribution from marijuana smoking cannot be ruled out. This result provides additional support for increasing smoking cessation and prevention programs for teenagers. The calendar-period decrease in lung cancer mortality after 1990 may reflect the long-term benefits of reductions in tobacco carcinogens in cigarettes and increases in smoking cessation beginning around 1960.


Subject(s)
Lung Neoplasms/mortality , Smoking/epidemiology , Adult , Black or African American/statistics & numerical data , Aged , Aged, 80 and over , Cohort Studies , Female , Humans , Lung Neoplasms/epidemiology , Lung Neoplasms/etiology , Male , Marijuana Smoking/epidemiology , Middle Aged , Mortality/trends , Prevalence , Risk , Sex Distribution , Smoking/adverse effects , United States/epidemiology , White People/statistics & numerical data
13.
Ann Epidemiol ; 10(7): 470, 2000 Oct 01.
Article in English | MEDLINE | ID: mdl-11018400

ABSTRACT

PURPOSE: The most recent atlas of cancer mortality in the United States revealed elevated prostate cancer mortality rates among white males in the northwest, Rocky Mountain, northcentral, and southeast areas, as well as New England, especially during the 1970-94 period. We wanted to test whether this observed geographic variation was simply due to chance or not.METHODS: We used a spatial scan statistic using mortality data for 506 state economic areas.RESULTS: There were four significant clusters with elevated risks of prostate cancer mortality (P < 0.001). The most prominent cluster was in the northwestern quadrant of the country, followed by clusters in New England, the midwest, and southeast regions. Within the northwestern cluster, we also detected seven significant sub-clusters (P < 0.05).CONCLUSIONS: We concluded that the observed geographic variation of prostate cancer mortality is indeed real, and deserves further study into the underlying determinants.

14.
Br J Cancer ; 82(11): 1875-8, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10839306

ABSTRACT

To evaluate positive findings from an earlier report, we studied the relation between retinoblastoma incidence and ultraviolet (UV-B) radiation levels in the Surveillance, Epidemiology, and End Results (SEER) programme areas of the USA using weighted regression, as well as in international data after adjusting for race, economic development, and climate. The association was not statistically significant within the USA (P > 0.20). At an international level, the relation was significant overall and after adjusting for economic development, but it was not significant after adjusting for race and tropical climate, suggesting that environmental factors other than UV-B may be responsible for the geographic patterns of retinoblastoma.


Subject(s)
Retinoblastoma/epidemiology , Ultraviolet Rays/adverse effects , Adolescent , Child , Child, Preschool , Humans , Incidence , Infant , Infant, Newborn , SEER Program
15.
J Natl Cancer Inst ; 92(10): 811-8, 2000 May 17.
Article in English | MEDLINE | ID: mdl-10814676

ABSTRACT

BACKGROUND: Mortality from melanoma among whites is still increasing in the United States. In this study, we describe the changing patterns of melanoma mortality rates among whites by demographic factors and geography and further assess the relationship between the geographic patterns and the UV radiation (UV-B) level. METHODS: Age-adjusted incidence and mortality rates were computed by use of the 1970 U.S. population standard. Annual percent changes of mortality were estimated by fitting regression lines to the logarithm of rates. The relationships between melanoma mortality rates and UV-B level over time were assessed by weighted regressions. All statistical tests were two-sided. RESULTS: From 1950-1954 through 1990-1994, melanoma mortality rates increased by 191% and 84% among males and females, respectively. Mortality rates peaked in the 1930 through 1950 birth cohorts for females and in the 1935 through 1950 birth cohorts for males. In the 1950 through 1969 study period, melanoma mortality rates showed a strong North-South gradient, but the gradient weakened in recent periods. The absolute change in mortality for a 10% increase in UV-B among females decreased from 0.08 additional deaths per 100 000 person-years in 1950-1959 to 0.01 additional deaths in 1990-1995. In contrast, the absolute change in mortality among males showed little change over time; additional deaths increased from 0.11 to 0.12 per 100 000 person-years. CONCLUSIONS: Melanoma mortality in the United States reflects the complex interplay of UV radiation levels in each geographic region, the sun-protection behaviors of each generation of males and females in childhood and adulthood, the geographic mobility of the population, and the risk awareness and early detection.


Subject(s)
Melanoma/mortality , Skin Neoplasms/mortality , White People/statistics & numerical data , Adult , Aged , Aged, 80 and over , Female , Geography , Humans , Male , Middle Aged , Population Surveillance , Time Factors , Ultraviolet Rays , United States
16.
Am J Ind Med ; 37(5): 512-21, 2000 May.
Article in English | MEDLINE | ID: mdl-10723045

ABSTRACT

BACKGROUND: Lung cancer mortality rates among white males in the United States were observed to be elevated during 1950-69 in counties with shipbuilding industries during World War II; risk was found to be associated with asbestos exposure. We evaluated the geographic patterns in more recent years, 1970-94, for whites and compared them with the 1950-69 patterns. METHODS: We calculated age-adjusted rates and estimated rate ratios between comparison groups. RESULTS: Rates generally were higher in shipyard counties than in all nonshipyard counties and in coastal nonshipyard counties for both sexes and time periods. Rates increased markedly from 1950-69 to 1970-94 in all groups, with the changes more pronounced in females than males. Pleural mesothelioma mortality rates were also significantly higher in shipyard counties than coastal nonshipyard counties in all regions among males but not among females. CONCLUSIONS: The more pronounced changes in lung cancer mortality rates among females in shipyard counties may be attributed to the combined effects of low asbestos exposures and changes in smoking behavior. Am. J. Ind. Med. 37:512-521, 2000. Published 2000 Wiley-Liss, Inc.


Subject(s)
Lung Neoplasms/mortality , Mesothelioma/mortality , Occupational Diseases/mortality , Pleural Neoplasms/mortality , Ships , Age Factors , Asbestos/adverse effects , Atlantic Ocean , Bronchial Neoplasms/mortality , Female , Humans , Male , Occupational Exposure/adverse effects , Pacific Ocean , Risk Factors , Rural Health/statistics & numerical data , Sex Factors , Smoking/epidemiology , Tracheal Neoplasms/mortality , United States/epidemiology , Urban Health/statistics & numerical data , White People
17.
Anal Biochem ; 265(1): 139-50, 1998 Dec 01.
Article in English | MEDLINE | ID: mdl-9866718

ABSTRACT

Sensitive and specific isotope dilution liquid chromatography/mass spectrometry (LC/MS) and liquid chromatography/tandem mass spectrometry (LC/MS/MS) methods were developed for the detection and quantitative analysis of S-[2-(N7-guanyl)ethyl]glutathione as a DNA adduct formed upon exposure of animals to carcinogenic 1,2-dihaloethanes. Separation and analysis were performed using microbore HPLC coupled in-line to an electrospray ionization triple quadrupole mass spectrometer. S-[2-(N7-guanyl)[2H4]-ethyl] glutathione was synthesized and used as internal standard. These methods provide structural confirmation of the adduct as well as quantitative analysis with the accuracy and precision necessary to measure biologically relevant levels in small tissue sample sizes (< 1 g). The sample detection limits in in vivo tissue extracts were 100 pg and 5 pg on-column for LC/MS and LC/MS/MS methods, respectively. Selected-ion monitoring mode was used to monitor the product ions of the doubly charged molecular ion. The application of these methods was demonstrated by measuring the DNA adduct levels in rat and fish samples after exposure to 1,2-dihaloethanes. The method has application in studies of DNA adduct formation as a biological marker of exposure to carcinogens and for environmental monitoring of 1,2-dihaloethanes.


Subject(s)
Chromatography, High Pressure Liquid/methods , DNA Adducts/analysis , Glutathione/analogs & derivatives , Mass Spectrometry/methods , Animals , Carcinogens/toxicity , Glutathione/analysis , Ictaluridae , Liver/chemistry , Male , Rats , Rats, Inbred F344
18.
Vet Res Commun ; 19(6): 479-85, 1995.
Article in English | MEDLINE | ID: mdl-8619286

ABSTRACT

The long-term impact of tsetse control on cattle population size in the Didessa Valley, western Ethiopia, was analysed using an age-structured population model. A prior analytical assessment revealed that the risk of cattle dying in the tsetse-unprotected villages ranged from 4 to 9 times higher than in the tsetse-protected village. Model results show that during a period of 10 years the cattle population in the tsetse-protected village of Meti is likely to increase from 167 to 583 animals, while that in the adjacent tsetse-unprotected village of Gale remains almost constant. Model simulations also predict that improving the survival rate of calves in the tsetse-unprotected villages of Taikiltu and Temoloko (which presently have calf mortality rates of up to 35% would bring a substantial increase in their cattle population.


Subject(s)
Cattle Diseases/prevention & control , Insect Control , Trypanosomiasis/veterinary , Tsetse Flies , Age Factors , Animals , Cattle , Cattle Diseases/epidemiology , Cattle Diseases/mortality , Ethiopia/epidemiology , Models, Biological , Population Density , Survival Rate , Trypanosomiasis/mortality , Trypanosomiasis/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...